|
|
|
Product Name
Version |
Current Prescribing
Information |
|
|
|
|
Aggrenox® Capsules
25 mg/200 mg
(aspirin/extended-release dipyridamole)
|
1/31/07
42633/US/7 |
Prescribing Information |
|
Alupent® Inhalation Aerosol
(metaproterenol sulfate) |
2/99
4041090 029 |
Prescribing Information |
|
Aptivus®
Capsules 250 mg
(tipranavir) |
October 2007
10003515/US/5 |
Prescribing Information |
Atrovent® HFA Inhalation Aerosol
(ipratropium bromide HFA) |
April 2008
10003001/US/5
|
Prescribing Information |
|
Atrovent® Inhalation Aerosol
(ipratropium bromide) |
3/02
10001403/01 |
Prescribing Information |
|
Atrovent® Nasal Spray 0.03%
(ipratropium bromide) |
December 2007
10001900/US/4 |
Prescribing Information |
|
Atrovent® Nasal Spray 0.06%
(ipratropium bromide) |
April 2008
4042182/US/06 |
Prescribing Information |
|
Catapres® Tablets 0.1,
0.2, and 0.3 mg
(clonidine hydrochloride) |
01/05/07
340066/US/3 |
Prescribing Information |
|
Catapres-TTS® Transdermal Therapeutic System
(clonidine) |
2/14/06
4044415/US/5
|
Prescribing Information |
|
Combivent® Inhalation Aerosol
(ipratropium bromide & albuterol sulfate) |
April 2008
10004145/US/03 |
Prescribing Information |
|
Flomax® Capsules 0.4 mg
(tamsulosin) |
March 2008
PRT52/US/1 |
Prescribing Information |
|
Micardis® HCT 40 mg/12.5 mg, 80 mg/12.5 mg and
80/25 mg
(telmisartan and hydrochlorothiazide) |
6/2/06
340139/US/4 |
Prescribing Information |
|
Micardis® Tablets 20mg, 40mg,
and 80mg
(telmisartan) |
5/25/06
340194/US/3 |
Prescribing Information |
|
Mirapex® Tablets
0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, and 1.5 mg
(pramipexole dihyrochloride) |
November 2007
10003128/US/5 |
Prescribing Information |
|
Mobic® Tablets 7.5 & 15mg
and
Oral Suspension 7.5 mg/5 mL
(meloxicam) |
April 2008
10003990/US/4 |
Prescribing Information
Medication Guide |
|
Persantine Tablets (dipyridamole USP)
25 mg, 50 mg, and 75 mg |
6/20/06
340067/US/7 |
Prescribing Information |
|
Spiriva®
HandiHaler®
(tiotropium bromide
inhalation powder) |
December
2007
10004551/US/3 |
Prescribing Information |
|
Viramune® Tablets 200 mg and
Oral
Suspension 50 mg/5 mL
(nevirapine) |
June 2007
10003354/US/2 |
Prescribing Information
Medication Guide |
|
|
|
|
|
|
|
|
|
Go to Top |
|